AAAAAA
Results:
1-10
|
Results: 10
Authors:
Beasley, CRW
Pearce, NE
Crane, J
Citation: Crw. Beasley et al., Epidemiology of asthma mortality, RESP PHARM, 2000, pp. 1-24
Authors:
Britton, JR
Lewis, SA
Citation: Jr. Britton et Sa. Lewis, Epidemiology of childhood asthma, RESP PHARM, 2000, pp. 25-56
Authors:
Taylor, DR
Sears, MR
Citation: Dr. Taylor et Mr. Sears, Is chronic use of beta(2)-agonists detrimental in the treatment of asthma?, RESP PHARM, 2000, pp. 57-72
Authors:
Parameswaran, K
Hargreave, FE
Citation: K. Parameswaran et Fe. Hargreave, Assessment of airway inflammation in asthma using non-invasive methods, RESP PHARM, 2000, pp. 73-95
Authors:
Pedersen, S
Citation: S. Pedersen, Treatment of asthma in children: the case for inhaled corticosteroids as first line agents, RESP PHARM, 2000, pp. 97-115
Authors:
Konig, P
Citation: P. Konig, Treatment of asthma in children: the case against inhaled corticosteroids as first line agents, RESP PHARM, 2000, pp. 117-128
Authors:
O'Bryne, PM
Citation: Pm. O'Bryne, Future trends in the use of corticosteroids in asthma, RESP PHARM, 2000, pp. 129-140
Authors:
Evans, DJ
Geddes, DM
Citation: Dj. Evans et Dm. Geddes, Steroid sparing therapies in asthma, RESP PHARM, 2000, pp. 141-170
Authors:
Chung, KF
Citation: Kf. Chung, Leukotriene receptor antagonists and 5-lipoxygenase inhibitors in asthma, RESP PHARM, 2000, pp. 171-189
Authors:
Page, CP
Costello, J
Citation: Cp. Page et J. Costello, Theophylline and new generation phosphodiesterase inhibitors in the treatment of asthma, RESP PHARM, 2000, pp. 191-202
Risultati:
1-10
|